Drug
Fab117 HC
Fab117 HC: highest development phase Phase 1/2, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| FAB117-HC NCT02917291 | Phase 1/2 | Acute Traumatic Spinal Cord Injury |
Latest
No recent events.
Follow Fab117 HC on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.